Evidity Health Capital
Growth equityNew York · Growth–Late Stage · 5 people tracked
Also known as EVIDITY CAPITAL LLC
Investment thesis
Evidity Health Capital is a late-stage venture capital and growth equity firm focused on the healthcare sector, specializing in medical devices, in vitro diagnostics, and disruptive digital health. The firm targets private companies that already have commercialized products and need growth capital to reach profitability. Its approach is described as value-focused, evidence-based, and business-building, aiming to support innovative and transformative healthcare businesses. The firm was previously known as Canepa Healthcare and is led by three investment partners with complementary skillsets and a shared background and approach.
Source: firm website, verified Aug 11, 2026.
Team · 5 people
from public directories
What they invest in
from 12 of 16 portfolio companiesHealthtech ×10Biotech ×4Medical Devices ×4Digital Health ×2AI & Machine Learning ×1Hardware ×1
HQs:United States×10
Investments · 16 tracked
founders shown can be your intro pathBy year:2026 · 12021 · 12020 · 22018 · 12016 · 16 dated
BiotechIrvine, US
Alan Waterhouse(President and Chief Operating Officer)Buzz Benson(Director)Arjun Arora(Director)Jason Tester(Chief Financial Officer and Secretary)Richard L. Lindstrom, M.D.(Director)James Garvey(Director)
HealthtechBoston, US
ERIC ELENKO(Executive Officer, Director)ROBERT PEREZ(Director)BHARATT CHOWRIRA(Director)W. EDWARD MARTUCCI(Executive Officer, Director)JAMES GATES(Director)JOICHI ITO(Director)
HealthtechSan Diego, US
Nicholas Barthelemy(Executive Officer, Director, Promoter)David Kabakoff(Director)Eric Bednarski(Director)
BoardAlejandro Sanchez(Director)
HealthtechSanta Clara, US
George Lee(Director)Lisa Garrett(Executive Officer)Michael Bornitz(Director)Rick Anderson(Director)John Russell(Executive Officer, Director)Augustine Lien(Director)
Tissue characterization technology company whose MarginProbe System detects cancer in real time during breast surgery.
EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices.
BiotechHealthtechMedical DevicesSan Mateo, US
Michael Carusi(Director)Scott Ward(Director)Arda Minocherhomjee(Director)Philip Macdonald(Executive Officer)Jordan Davis(Director)Lee Wrubel, M.D.(Director)
GammaTile Therapy, a surgically targeted radiation therapy for operable brain tumors
HealthtechTempe, US
David G. Brachman(Executive Officer, Director)Per Langoe(Executive Officer, Director)Jason Rostovsky(Director)James Leech(Executive Officer)Radu Cautis(Director)Matthew E. Likens(Executive Officer, Director)
Magnolia Medical develops the Steripath® platform, an FDA-cleared medical device designed to reduce blood culture contamination and improve diagnostic accuracy for sepsis testing in hospital settings.
Digital HealthHealthtechMedical DevicesSeattle, US
Paul Meister(Director)Richard G Patton(Director)Gregory J Bullington(Executive Officer, Director)
HealthtechPembroke Pines, US
Horace Richard Davis(Executive Officer)
PreludeDx develops DCISionRT, a biomarker-based diagnostic test for ductal carcinoma in situ (DCIS) breast cancer that helps physicians predict a patient's recurrence risk and whether they would benefit from radiation therapy after breast-conserving surgery.
BiotechHealthtechMedical Devices
Sonde provides an API/SDK platform that analyzes vocal biomarkers to detect health signals from voice, offering insights into users' mental, cognitive, and respiratory fitness.
AI & Machine LearningDigital HealthHealthtech
BiotechCambridge, US
Nathaniel Weiss(Executive Officer, Director)David Artz(Director)Andrew Smith(Director)
Portfolio news
latest coverage across their companiesGT Medical Technologies · intelligence360.news · Jun 25, 2026
Magnolia Medical Technologies · nasdaqprivatemarket.com · Oct 21, 2025
Frequently asked questions
- What stage does Evidity Health Capital invest at?
- Evidity Health Capital invests at the Growth, Late Stage stages.
- What is Evidity Health Capital's typical check size?
- Evidity Health Capital typically writes checks of $5M.
- What sectors does Evidity Health Capital focus on?
- Evidity Health Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Evidity Health Capital located?
- Evidity Health Capital is headquartered in New York, US.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.